118 related articles for article (PubMed ID: 16289277)
1. An autoimmune domain-reduced HCV core gene remains effective in stimulating anti-core cytotoxic T lymphocyte activity.
Liu Y; Zhou W; You C; Zheng H; You H; Liu H; Zhang D; Luo R; Kay HH; Hermonat PL
Vaccine; 2006 Mar; 24(10):1615-24. PubMed ID: 16289277
[TBL] [Abstract][Full Text] [Related]
2. HBV genes induce cytotoxic T-lymphocyte response upon adeno-associated virus (AAV) vector delivery into dendritic cells.
You H; Liu Y; Cong M; Ping W; You C; Zhang D; Mehta JL; Hermonat PL
J Viral Hepat; 2006 Sep; 13(9):605-12. PubMed ID: 16907847
[TBL] [Abstract][Full Text] [Related]
3. Generation of robust cytotoxic T lymphocytes against prostate specific antigen by transduction of dendritic cells using protein and recombinant adeno-associated virus.
Mahadevan M; Liu Y; You C; Luo R; You H; Mehta JL; Hermonat PL
Cancer Immunol Immunother; 2007 Oct; 56(10):1615-24. PubMed ID: 17356843
[TBL] [Abstract][Full Text] [Related]
4. Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and function.
You CX; Liu Y; Shi M; Cao M; Luo RC; Hermonat PL
Cancer Immunol Immunother; 2010 May; 59(5):779-87. PubMed ID: 20091029
[TBL] [Abstract][Full Text] [Related]
5. Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cells.
Liu Y; Chiriva-Internati M; You C; Luo R; You H; Prasad CK; Grizzi F; Cobos E; Klimberg VS; Kay H; Mehta JL; Hermonat PL
Cancer Gene Ther; 2005 Mar; 12(3):304-12. PubMed ID: 15565181
[TBL] [Abstract][Full Text] [Related]
6. [rAAV/BA46-transfected dendritic cells can induce specific cellular immunity].
You CX; Su J; Liao WJ; Zhang JY; Liu Y; Paul LH; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2146-9. PubMed ID: 19114342
[TBL] [Abstract][Full Text] [Related]
7. Functional measurement of hepatitis C virus core-specific CD8(+) T-cell responses in the livers or peripheral blood of patients by using autologous peripheral blood mononuclear cells as targets or stimulators.
Fang SH; Chiang BL; Wu MH; Iba H; Lai MY; Yang PM; Chen DS; Hwang LH
J Clin Microbiol; 2001 Nov; 39(11):3895-901. PubMed ID: 11682504
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic capacity of hepatitis C virus (HCV)--specific lymphocytes after in vitro immunization with HCV-derived lipopeptides.
Langhans B; Schweitzer S; Braunschweiger I; Schulz M; Sauerbruch T; Spengler U
Cytometry A; 2005 May; 65(1):59-68. PubMed ID: 15800857
[TBL] [Abstract][Full Text] [Related]
9. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs.
Tokushige K; Wakita T; Pachuk C; Moradpour D; Weiner DB; Zurawski VR; Wands JR
Hepatology; 1996 Jul; 24(1):14-20. PubMed ID: 8707253
[TBL] [Abstract][Full Text] [Related]
10. Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector.
Liu Y; Chiriva-Internati M; Grizzi F; Salati E; Roman JJ; Lim S; Hermonat PL
Cancer Gene Ther; 2001 Dec; 8(12):948-57. PubMed ID: 11781657
[TBL] [Abstract][Full Text] [Related]
11. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.
Nelson DR; Marousis CG; Davis GL; Rice CM; Wong J; Houghton M; Lau JY
J Immunol; 1997 Feb; 158(3):1473-81. PubMed ID: 9013994
[TBL] [Abstract][Full Text] [Related]
12. [Generation of antitumor response against hepatocellular carcinoma by in vitro transduction of dendritic cells with adeno-associated virus expressing α-fetoprotein].
Du WZ; Yu TX
Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(29):2077-80. PubMed ID: 22093940
[TBL] [Abstract][Full Text] [Related]
13. Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responses.
Jirmo AC; Koya RC; Sundarasetty BS; Pincha M; Yu GY; Lai M; Bakshi R; Schlaphoff V; Grabowski J; Behrens G; Wedemeyer H; Stripecke R
Vaccine; 2010 Jan; 28(4):922-33. PubMed ID: 19931383
[TBL] [Abstract][Full Text] [Related]
14. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
Urbani S; Uggeri J; Matsuura Y; Miyamura T; Penna A; Boni C; Ferrari C
Hepatology; 2001 Jun; 33(6):1533-43. PubMed ID: 11391544
[TBL] [Abstract][Full Text] [Related]
15. Functional change of human peripheral blood monocyte-derived dendritic cells after recombinant adeno-associated virus type 2-mediated HBsAg gene infection.
Hu GF; Wu XB; Yu SY; Kang Y; Hou YD
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jul; 23(7):696-8, 701. PubMed ID: 12865224
[TBL] [Abstract][Full Text] [Related]
16. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
17. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
[TBL] [Abstract][Full Text] [Related]
18. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
[TBL] [Abstract][Full Text] [Related]
19. [Impaired non-viral specific immune function of dendritic cell does not interfere with clearance and cytotoxic T lymphocyte response to HBV or HCV].
Fan CL; Chen HS; Li RB; Wang SX; Cong X; Fei R; Jiang D; Wang Y; Wei L
Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):67-71. PubMed ID: 14980100
[TBL] [Abstract][Full Text] [Related]
20. Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response.
Thammanichanond D; Moneer S; Yotnda P; Aitken C; Earnest-Silveira L; Jackson D; Hellard M; McCluskey J; Torresi J; Bharadwaj M
Clin Immunol; 2008 Sep; 128(3):329-39. PubMed ID: 18524682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
